Eton Pharmaceuticals, Inc. (ETON)
54.89
-2.73
(-4.74%)
USD |
NASDAQ |
Sep 15, 12:04
Eton Pharmaceuticals 1 Year Total Returns (Daily) : 226.5% for Sept. 14, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 14, 2026 | 226.5% |
| September 11, 2026 | 224.9% |
| September 10, 2026 | 232.3% |
| September 09, 2026 | 229.6% |
| September 08, 2026 | 233.8% |
| September 04, 2026 | 227.1% |
| September 03, 2026 | 243.3% |
| September 02, 2026 | 260.4% |
| September 01, 2026 | 249.1% |
| August 31, 2026 | 249.2% |
| August 28, 2026 | 245.9% |
| August 27, 2026 | 262.7% |
| August 26, 2026 | 258.6% |
| August 25, 2026 | 268.9% |
| August 24, 2026 | 272.4% |
| August 21, 2026 | 271.4% |
| August 20, 2026 | 262.0% |
| August 19, 2026 | 279.5% |
| August 18, 2026 | 287.5% |
| August 17, 2026 | 262.3% |
| August 14, 2026 | 252.5% |
| August 13, 2026 | 138.3% |
| August 12, 2026 | 140.1% |
| August 11, 2026 | 146.6% |
| August 10, 2026 | 154.8% |
| Date | Value |
|---|---|
| August 07, 2026 | 192.3% |
| August 06, 2026 | 202.6% |
| August 05, 2026 | 212.1% |
| August 04, 2026 | 218.5% |
| August 03, 2026 | 219.5% |
| July 31, 2026 | 227.8% |
| July 30, 2026 | 237.7% |
| July 29, 2026 | 233.5% |
| July 28, 2026 | 210.4% |
| July 27, 2026 | 174.7% |
| July 24, 2026 | 177.1% |
| July 23, 2026 | 188.7% |
| July 22, 2026 | 198.7% |
| July 21, 2026 | 200.0% |
| July 20, 2026 | 173.4% |
| July 17, 2026 | 203.4% |
| July 16, 2026 | 167.7% |
| July 15, 2026 | 166.8% |
| July 14, 2026 | 158.0% |
| July 13, 2026 | 157.7% |
| July 10, 2026 | 135.3% |
| July 09, 2026 | 136.7% |
| July 08, 2026 | 128.9% |
| July 07, 2026 | 162.3% |
| July 06, 2026 | 163.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Nektar Therapeutics | 40.71% |
| Pfizer Inc. | 24.31% |
| Elite Pharmaceuticals, Inc. | -62.83% |
| Daré Bioscience, Inc. | -65.10% |
| Liquidia Corp. | 151.3% |